These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25456656)

  • 1. Competitive binding of Chlorin p6 and Dansyl-l-Proline to Sudlow's site II of human serum albumin.
    Patel S; Sharma KK; Datta A
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Mar; 138():925-31. PubMed ID: 25456656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady state and time-resolved fluorescence investigation of the specific binding of two chlorin derivatives with human serum albumin.
    Patel S; Datta A
    J Phys Chem B; 2007 Sep; 111(35):10557-62. PubMed ID: 17705527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual binding of a potential biomarker with human serum albumin.
    De D; Kaur H; Datta A
    Chem Asian J; 2013 Apr; 8(4):728-35. PubMed ID: 23404770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin.
    Chen YM; Guo LH
    Arch Toxicol; 2009 Mar; 83(3):255-61. PubMed ID: 18854981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluoroalkane sulfonyl fluorides non-covalently bind to human serum albumin at Sudlow's sites.
    Jin Z; Chi M; He Q; Pan Y; Sun C
    Toxicol Lett; 2019 Feb; 301():17-23. PubMed ID: 30408508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism.
    Okabe N; Hashizume N
    Biol Pharm Bull; 1994 Jan; 17(1):16-21. PubMed ID: 8148809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into the binding mechanism of imipenem to human serum albumin by spectroscopic and computational approaches.
    Rehman MT; Shamsi H; Khan AU
    Mol Pharm; 2014 Jun; 11(6):1785-97. PubMed ID: 24745377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme impairs allosterically drug binding to human serum albumin Sudlow's site I.
    Ascenzi P; Bocedi A; Notari S; Menegatti E; Fasano M
    Biochem Biophys Res Commun; 2005 Aug; 334(2):481-6. PubMed ID: 16004963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug binding to Sudlow's site I impairs allosterically human serum heme-albumin-catalyzed peroxynitrite detoxification.
    Ascenzi P; Bolli A; Gullotta F; Fanali G; Fasano M
    IUBMB Life; 2010 Oct; 62(10):776-80. PubMed ID: 20979209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR and Docking Calculations Reveal Novel Atomistic Selectivity of a Synthetic High-Affinity Free Fatty Acid vs. Free Fatty Acids in Sudlow's Drug Binding Sites in Human Serum Albumin.
    Venianakis T; Primikyri A; Opatz T; Petry S; Papamokos G; Gerothanassis IP
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the interaction of levocetirizine dihydrochloride with human serum albumin by molecular spectroscopy.
    Liu X; Du Y; Sun W; Kou J; Yu B
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Dec; 74(5):1189-96. PubMed ID: 19857990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Displacement of Drugs from Human Serum Albumin: From Molecular Interactions to Clinical Significance.
    Rimac H; Debeljak Ž; Bojić M; Miller L
    Curr Med Chem; 2017; 24(18):1930-1947. PubMed ID: 28155602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining molecular binding sites on human serum albumin by displacement of oleic acid.
    Sarver RW; Gao H; Tian F
    Anal Biochem; 2005 Dec; 347(2):297-302. PubMed ID: 16289007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of chlorin p6 with bovine serum albumin and photodynamic oxidation of protein.
    Bose B; Dube A
    J Photochem Photobiol B; 2006 Oct; 85(1):49-55. PubMed ID: 16762562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the enantioselective interaction of diclofop and human serum albumin by spectroscopic and molecular modeling approaches in vitro.
    Zhang P; Li Z; Wang X; Shen Z; Wang Y; Yan J; Zhou Z; Zhu W
    Chirality; 2013 Nov; 25(11):719-25. PubMed ID: 23857454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cephalosporin binding sites to human serum albumin and the relation with the N-B transition of this protein.
    Nerli B; García F; Ballán C; Picó G
    Biochem Mol Biol Int; 1995 May; 36(1):177-84. PubMed ID: 7663413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the binding of chiral drug duloxetine hydrochloride to human serum albumin.
    Liu X; Du Y
    Eur J Med Chem; 2010 Sep; 45(9):4043-9. PubMed ID: 20646793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the binding mechanism of ondansetron hydrochloride to serum albumins: spectroscopic approach.
    B S; Hegde AH; K C R; J S
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Feb; 86():410-6. PubMed ID: 22112579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-Specific Binding of Anti-Cancer Drugs to Human Serum Albumin.
    Bhosale M; Jeelani I; Nawaz A; Abe H; Padhye S
    Anticancer Agents Med Chem; 2022 Aug; 22(16):2876-2884. PubMed ID: 35331098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pyrazosulfuron-ethyl binding affinity and binding site subdomain IIA in human serum albumin by spectroscopic methods.
    Ding F; Liu W; Zhang X; Wu LJ; Zhang L; Sun Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Mar; 75(3):1088-94. PubMed ID: 20064739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.